Noble Capital Markets, Inc. (“Noble”) announced today that country star Eric Paslay (with hits like “Friday Night”) will join leading experts to offer a patient perspective on the Type 1 Diabetes (T1D) panel “A Functional Cure Could Be Imminent,” at Noble’s sixteenth annual small & microcap investor conference (NobleCon16) to be held February 16-18, 2020, at the new flagship Hard Rock Guitar Hotel, located 10 minutes west of Fort Lauderdale International Airport.
Noble Capital Markets, Inc. (“Noble”) announces today the addition of former JSB Partners principals Michel Gouy and Wolfgang Stoiber to its Noble Life Science Partners division (“NLSP”).
Noble Capital Markets and OTC Markets Group invite you to join a webinar discussing the importance of third-party research. Learn why establishing a dialogue with your investment community holds a significant purpose and how to achieve your company's mission through institutional-quality research.
Noble Capital Markets Inc. announces the launch of its first College Research Report Challenge, designed to encourage college students to explore employment in the field of equity analysis.
Noble Capital Markets announced today that it will donate $500 to the Official Hurricane Dorian Relief Effort for every company that registers for its sixteenth annual NobleCon small & microcap investor conference from today through October 31, 2019. Furthermore, additional donations of $100 will be made for each investor registration.
Noble Financial Group, Inc. (“Noble”) announces today that it has launched a new podcast series on its investor portal, Channelchek.com. The series, entitled “IPO” (which stands for “Ideas,” “People behind them” and “Opportunities they create”), is hosted by award-winning director and producer Brant Pinvidic.
QuoteMedia, Inc. (QMCI), a leading provider of market data and financial applications, is pleased to announce that Noble Capital Markets, Inc. has initiated coverage of QuoteMedia – assigning an initial rating of Outperform with a Target Price of $0.25/share.
NOBLE Capital Markets received the 2018 Deal of the Year under the “Follow-on Equity Offering” category by Marine Money during the 32nd annual Marine Money Week on June 17-19, 2019 at the Pierre Hotel in New York City.
A Leader in the High Performance Computing Space
Building a Future on Copper.
Successful Energy Marketer Is Set To Expand
Bank says investor meetings outside the traditional hotbeds of north-eastern US cities can pay dividends for an industry in need of support wherever it can be found.
US-based companies try to separate from the pack in an industry with a poor track-record on good standards.
Our SAB is a strategic resource whose experience, relationships, and knowledge are utilized throughout NOBLE Life Science Partners to enhance all service offerings. Through the SAB, we have access to world-class healthcare professionals for substantive advice regarding new discoveries, technologies, products, services, and developments.
Offering is expected to make $100.7m for US-listed drybulker owner to pursue fleet expansion.
ProMIS Neurosciences Inc. (TSX:PMN; OTCQB:ARFXF) is pleased to announce that it closed yesterday a private placement of 19,306,668 Units at the price of CDN$0.375 per Unit for gross proceeds of approximately CDN$ 7,240,000.
OSG chief executive Sam Norton tells Noble Capital conference that gains over last five months appear to be holding up. The first signs of a recovery may be showing for tanker rates in the recently slumping US Jones Act market.
Finance experts say dry bulk sector is most favourable starting point in 2018 - but they are not exactly issuing guarantees as mergers may be the flavour of the year
Gray Television, Inc. (NYSE: GTN and GTN.A) announced today that it has completed its previously announced and priced underwritten public offering of shares of its common stock at a price to the public of $14.50 per share.
VBI Vaccines Inc. (Nasdaq: VBIV) (TSX: VBV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced that the underwriters of its previously announced underwritten public offering have exercised their option to purchase an additional 2,100,000 shares.